Greenville pharmaceutical plant adding 500 new jobs
GREENVILLE, N.C. (WITN) - A pharmaceutical company says it will add 500 new jobs at its Greenville plant.
Thermo Fisher Scientific plans to invest $500 million to expand its U.S. 264 location with a new 130,000 square foot facility.
The expansion will serve sterile drug product development and commercial manufacturing.
This comes as the global demand for injectable sterile drugs increases with 46 percent of total dosage forms securing U.S. FDA approval in 2019, according to PharmaSource and the FDA.
The site will also add six new lines in 2021 and 2022, including commercial scale liquid filling lines and a development line for liquid and lyophilized (freeze-dried) drug products.
The company currently employs more than 1,500 people at the Greenville plant.
Thermo Fisher expects to hire the new workers over the next 12 to 24 months and says the company supports more than 250 COVID-19 related projects globally.
But not only will it bring jobs to Greenville.. the economic growth will be seen all over Eastern North Carolina.
Thermo Fisher told WITN that the requirements for these new jobs range from a HS diploma to advanced degrees depending on the job.
To learn more about the job openings you can visit the link below:
The expansion construction has begun on the new production lines in the current Thermo Fisher Building, and on the new building itself.
The new production lines are expected to be done in 2021 and 2022 while the new building is expected to be complete in 2022.
The company has over 75,000 employees worldwide and annual revenue of more than $25 billion.
The Greenville – ENC Alliance is actively working with a range of local partners to help develop the future workforce to meet the needs of Thermo Fisher and other regional pharmaceutical companies. Partners include the City of Greenville, Pitt County, NC Biotechnology Center, Pitt County Public Schools, Pitt Community College, and East Carolina University.
Copyright 2020 WITN. All rights reserved.